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ABSTRACT
M. KATHERINE CLOUD: A Study of the Dynamic Relationships between Depression,
Treatment, and Work Behavior
(Under the direction of Donna B. Gilleskie)
It has been shown in the literature that depression has a significant negative correlation
with employment outcomes as measured by labor force participation, earnings, work atten-
dance and job performance. I expand the understanding of this relationship by exploring
the effect of depression on employment choices as well as treatment choices over time rather
than simply examining correlations at a point in time. Other health related outcomes and
the relationship between choices and mental health will be examined. My analysis follows
initially depressed individuals for nine months and examines the dynamic relationship be-
tween health status and function, treatment decisions and employment outcomes. I consider
a dynamic model of individual decisions over time where lagged endogenous behavior is al-
lowed to influence current behavior or health outcomes. Results indicate that depression
does have a significant effect on labor productivity. Individuals who were the most depressed
at the baseline interview saw the largest improvements in productivity following treatment.
However, the estimates imply that depression is not a significant determinant of the worker’s
attendance at work.
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Chapter 1
Introduction
The impact of mental health on the labor market is a topic of increasing interest to em-
ployers, policy makers, and to both labor and health economists. Following the findings of
the Harvard School of Public Health in its 1996 (updated in 2003) study “Global Burden
of Disease (GBD),” the Global Business and Economic Roundtable on Addiction and Mental
Health was formed in 1998. The Roundtable consists of business and health leaders who
have proposed that mental health is a business and economic issue.1 They highlight the fact
that mental health problems are driving disability rates within the North American labor
force representing significant social and business costs and leading to lower productivity. The
global information economy is, by definition, dependent on mental performance. Therefore,
mental health among the labor force is a significant determinant of output much like physical
health was in the industrial economy. Mental health is also closely tied to a depressed individ-
ual’s physical health, notably, heart disease and fatigue. In the public sector, congressional
lawmakers and mental health experts are discussing ways to meet the goals laid out in The
President’s New Freedom Commission on Mental Health.2
The term mental illness includes a vast array of diseases causing varying levels of lim-
itations. Major depressive disorder, also known as major depression, unipolar depression,
clinical depression or simply depression, is a common mental disorder characterized by a per-
vasive low mood, loss of interest in a person’s usual activities, diminished ability to experience
1They base this proposal on four facts drawn from the Harvard and other studies.
2The commission from the George W. Bush Administration, 2002, pinpoints a range of mental health
challenges.
pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, low energy and poor
concentration. It is the most widespread of all psychiatric disorders and one of the most com-
mon medical conditions in the United States. It has been estimated that depression affects
18.8 million Americans each year, aﬄicting between 10 and 25 percent of American women
and between five and 12 percent of men in their lifetime (Kessler et al., 2005).
The Harvard Study reports that in 2000, depression was estimated to be the fourth leading
contributor to the global burden of disease, and today, depression is already the second
cause of Disability Adjusted Life Years (DALYs) in the age category 15-44 years for both
sexes combined.3 The same study estimated that by 2020, only ischemic heart disease will
contribute a larger worldwide economic burden in DALYs calculated for all ages, both sexes.
These projections show that with the aging of the world population and the conquest of
infectious diseases, psychiatric and neurological conditions could increase their share of the
total global disease burden by almost half, from 10.50% of the total burden to almost 15.00%
in 2020.
This burden results from both direct health care costs and indirect costs including effects
in the labor market, high correlation with poor physical health, suicide and disability costs.
Greenberg et al. (2003) estimated that the United States spent $83.10 billion in 2000 for costs
associated with depression, an increase from $77.40 billion in 1990. The direct treatment costs
were estimated to account for 31.40% of the total costs for depression, with workplace costs
making up 62.00% of the economic costs of depression (Greenberg et al., 2003). Multiple
studies have shown people with depression also have higher total healthcare utilization rates
when compared to individuals without depression. The Health Enhancement Research Or-
ganization (HERO) analyzed employee medical costs for 46,000 employed persons and found
that of the health risk factors studied (smoking, sedentary lifestyle, high cholesterol levels,
hypertension, poor diet, being overweight, excessive alcohol consumption, high blood glucose
3The Harvard Global Burden of Disease study developed a single measure to allow comparison of the burden
of disease across many different disease conditions by including both death and disability. This measure was
called Disability Adjusted Life Years (DALYs). DALYs measure lost years of healthy life regardless of whether
the years were lost to premature death or disability. The disability component of this measure is weighted for
severity of the disability. For example, disability caused by major depression was found to be equivalent to
blindness or paraplegia whereas active psychosis seen in schizophrenia produces disability equal to quadriplegia.
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levels, high stress and depression), depression predicted the largest increase in medical costs.
The HERO study estimated that depression predicted a 70.00% increase in medical costs
compared to medical costs for those without depression. Another study noted that depressed
employees use, on average, more than $4000 per year in medical services compared to less
than $1000 per year for those without depression indicating that depression is a significant
element in rising healthcare costs (Sipkoff, 2006). Both direct and indirect costs will vary
based on the severity of the depression.
In the labor market, depressed individuals are less likely to be employed, more likely to be
absent if employed and have lower productivity while at work. Compounding the effect, many
affected individuals are in the prime of their working lives, unlike other disabling conditions
that often occur later in life. The GBD study estimated that major depression is the single
most burdensome illness in the middle life years.
The costs related to depression often come in the form of lower productivity (due to
reduced cognitive abilities or impaired concentration) while at work, called presenteeism, and
a higher number of missed days of work, termed absenteeism. Data from the Epidemiological
Catchment Area (ECA) and the National Comorbidity Study (NCS) provide estimates of the
annual total cost of depression at $43.70 billion in 1990. Employment effects were substantial:
$11.70 billion for work absenteeism and $12 billion for reduced productivity. A 1996 reestimate
of the losses totaled $53 billion (Swindle et al., 2001). Other estimates have been as high as
$51.50 billion a year in lost productivity (Lerner et al., 2004).
Many studies address issues concerning either mental health or depression and labor out-
comes. These studies are primarily static, considering only one time period or using repeated
cross sections, despite the fact that depression is a recurring disease for the individual. It is
estimated that of individuals who have had a single major depressive episode, 50%-60% may
develop a second episode within 10 years of the initial episode. About 90% of those who have
had two episodes may have a third. The relapse rate is estimated to be 40% within 15 weeks
among persons who have had at least three lifetime episodes and a relapse rate of 65% within
the first year, if left untreated, for these individuals (Bloom, 2004).
A few studies use panel data but can only report an association between depression and
3
work outcomes. They do not account for treatment decisions and efficacy or they do not
address individual unobserved heterogeneity that may affect the individual’s decisions and
outcomes.
The ideal data set would detail the health, labor and demographic characteristics of a
nationally representative sample of individuals followed over time. In reviewing the literature,
there were not any studies that use data with all of these characteristics. I use the ARTIST
(A Randomized Trial Investigating SSRI 4 Treatment) trial data which has the advantages
of including many health measures (both physical and mental) and labor questions asked
together with a substantial amount of geographic variation. It is in the form of a panel and
follows 573 individuals for 9 months. Disadvantages include the fact that these data are
based on self report, the data only cover a nine-month period and all of the individuals are
depressed at baseline causing selection bias issues. The purpose of the trial was to investigate
the efficacy of specific SSRI treatments on depressed primary care patients.
The contributions of this dissertation follow: This study extends the models estimated
with panel data by allowing for potential dynamic relationships between depression and em-
ployment over time, considering the role of treatment in affecting both health transitions as
well as observed employment outcomes, using the time series element of the data to address
instrumentation and using multiple measures of depression and labor outcomes.
The remainder of this dissertation is organized in the following chapters. Chapter 2
contains a literature review. Chapter 3 describes the data. Chapter 4 presents a theoretical
model. The empirical model is found in Chapter 5. Chapter 6 discusses results. Chapter 7
concludes, discussing implications for policy formulation and further research.
4Selective Serotonin Reuptake Inhibitors (SSRIs) are the most commonly prescribed class of antidepressants.
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Chapter 2
Background
The literature confirms an association between depression and employment probabilities,
presenteeism and absenteeism. It further suggests that there are substantial employer costs
associated with the employment of depressed individuals.
Using data from the National Comorbidity Survey (NCS)1 to identify the importance of
depression in the labor force, Marcotte et al. (1999) find that rates of depression are similar
in and out of the labor force. However, they report that within the labor force, depression
is strongly associated with unemployment, with a particularly strong relationship for middle
age workers. Using an instrumental variables approach, Ettner et al. (1997) find a decrease
in the employment probability for both women and men with major depression. Mullahy and
Sindelar (1990) show that mental health was a significant determinant of the probability of
full-time work for New Haven adults. Broadhead et al. (1990) find similar results and report
that persons with minor depression were more likely to be unemployed. In more recent work,
Lerner et al. (2004) report that all forms of depression lead to significant increases in job
turnover. Specifically focusing on employed individuals with depression, they report that at
the six-month follow-up, unemployment rates had increased by 12% for the participants in the
major depression group, compared with 2% for individuals in the control group and 3% for
those affected by rheumatoid arthritis. The same study reports that “among participants who
were still employed, those with depression had significantly more job turnover, presenteeism
1The NCS is a nationally representative sample. It is longitudinal and cross-sectional and only compares
cohorts of individuals rather than a specific individual over the life cycle.
and absenteeism.”
Depite higher unemployment rates for depressed individuals, it has been estimated that
more than 70 percent of people diagnosed with depression are employed (Lerner et al., 2004).
Estimates have varied with respect to whether depression impacts productivity costs predom-
inantly through absenteeism or presenteeism.
Kessler et al. (2001) find that employed patients with psychiatric disorders (including
depression) had significantly greater mean monthly number of work loss days (0.25) and work
cutback days (1.09) compared to people with no disorders. Druss et al. (2001), using data
from three major American companies, report that those who displayed chronic symptoms of
depression were twice as likely to miss work due to health reasons, and seven times as likely
to report missed work days at the time of the follow up survey. Bill Wilkerson2 reports in
his speech “Mental Health: The Ultimate Productivity Weapon in the Post- September 11th
economy” that the average number of workdays lost to one case of depression is about forty or
$10,000 per absent employee for wage replacements and the company’s share of drug therapies
with a group health benefit plan. In more recent studies, Kessler et al. (2006) studied work
impairment due to chronic conditions including major depression. They report estimates that
major depressive disorder was associated with 27.20 lost workdays per ill worker per year.
The indirect costs of depression continue to increase when considering lowered productivity
(due to reduced cognitive abilities or impaired concentration) while at work, or presenteeism.
Brouwer et al. (2002) report that presenteeism can occur before and after absence from
work. Berndt et al. (1998) find that perceived work performance is inversely related to the
severity of depression and that a reduction in depression severity is associated with a rapid
improvement in perceived work performance. In their study to explain depression’s effect on
work productivity, they use panel data with three interviews per individual over a 12-week
period. They do not address the issue of unobserved heterogeneity and explain much of the
change in outcomes as regression to the mean. Von Korff et al. (1992) evaluated untreated
depressed patients who frequently used health care in a Health Maintenance Organization
2He is the Co-Founder and CEO, Global Business and Economic Roundtable on Addiction and Mental
Health.
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over a period of 12 months. Respondents whose depression did not improve over the period
reported very high levels of work impairment that did not change significantly. In comparison,
respondents with depression rated as severe at baseline whose depression did improve over
the follow-up reported a 36% reduction in work impairment days. The study does use panel
data. However, these results do not prove that the reduced productivity is a consequence of
the depression. Another possibility is that some other unmeasured variable (e.g., difficulty in
getting along with a work supervisor) increases both depression and work impairment. The
purpose of the Von Korff et al. (1992) study was primarily medical and the results are based
on associations between depressive episode improvement and work impairment. Stewart et al.
(2003) use data from the American Productivity Audit in 2001-2002. They find that depressed
individuals had 5.6 hours per week more lost productive time than non-depressed workers.
They conclude that 81% of the lost productive time was due to presenteeism. In this study,
excess lost productive time (LPT) costs from depression were derived as the difference in LPT
for depressed individuals minus the expected LPT for non-depressed individuals projected to
the US labor force. Again, they do not account for individual differences or treatment decisions
and outcomes. Using data from 16,651 employees, Burton et al. (2004) demonstrated that
depression was highly associated with work limitations that predict a worker’s productivity
while on the job, including limitations in time management, interpersonal/mental functioning,
and overall output.
It is important to address the treatment decision in any study of depression. Between
80 and 90 percent of individuals suffering from a major depressive disorder can be treated
successfully, yet the National Institute of Mental Health estimates that only one in three
with the illness ever seek treatment. Among a depressed sample, absenteeism is reduced
and productivity improves regardless of treatment choice3 (Mintz et al. 1992, Simon et al.
1998). In 1992, Mintz et al. (1992) looked at different studies that evaluated the effects of
antidepressants and psychotherapy on work impairment. Work outcomes were generally good
when the treatment choice was effective. Relapse was found to be a consistent predictor of
3In this research, treatment choices are of short-term medications, psychotherapy lasting 10 to 16 weeks,
and maintenance therapy over 6 to 9 months.
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long-term work impairment. When considering treatment, Claxton et al. (1999) showed that
absenteeism increased prior to antidepressant use, and decreased after treatment began.
Many aspects of the relationships between depression, labor outcomes, and treatment
decisions have been addressed in the existing literature. Most studies are found in medical
or policy literature and fail to control for many factors. Many separate their sample into
two groups, a treatment and a control group. Or, they just look at the changes in outcome
variables without controlling for any characteristics, either observable or unobservable, other
than depression.
In the economics literature, the majority of studies are based on cross section data and
do not investigate the role of permanent unobserved heterogeneity on these outcomes. Longi-
tudinal studies are rare, but do exist. However, they rarely incorporate treatment decisions.
I will extend this previous research by focusing on the relationships between depressive
disorders, treatment decisions and multiple labor outcomes. The specific goals of the study
are to: (i) estimate the impact of depression on labor outcomes while accounting for perma-
nent unobserved heterogeneity in order to get unbiased estimates of depression’s effects on
labor outcomes, (ii) to incorporate treatment decisions into a model that uses different labor
outcomes and varying measures of depression (including continuous, binary and categorical
scales) and (iii) to use The Generalized Methods of Moments estimator and lags of endogenous
regressors as instruments since no time-varying instruments are readily available.
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Chapter 3
Data Description
3.1 ARTIST trial
Much effort was made to find a data set with varying health and employment measures
that followed individuals over time in order to capture the effect of a potentially changing (ei-
ther improving or worsening) depressive state on work behavior. Through special agreement
with the pharmaceutical manufacturer Eli Lilly, I have obtained access to the ARTIST (A
Randomized Trial Investigating SSRI Treatment) trial data. These data were collected over
a 9-month period with enrollment occurring between April and November 1999. The partic-
ipants were recruited from 37 clinical practices in two primary care research networks: the
Primary Care Network (PCN)1 and the Duke Primary Care Research Consortium (DPCRC).2
Overall, 77 practitioners participated in the ARTIST trial, 51 from the PCN and 26 from the
DPCRC. To be eligible to participate in the study, individuals had to be at least 18 years
of age, receive their primary care from a physician participating in the PCN or DPCRC,
have access to a home telephone, and be diagnosed with a depressive disorder. There were
also exclusionary restrictions. Restrictions included: being actively suicidal, cognitive impair-
ment, terminal illness, nursing home residence, taking an SSRI currently or within the last
two months, taking a non- SSRI antidepressant at more than low doses, history of bipolar
disorder, active cocaine or opiate user, and pregnant or breast feeding. The purpose of the
1The PCN is a not-for-profit voluntary organization and nationwide network of primary care practitioners
whose goal is to optimize the care they provide by continuing education.
2The DPCRC is an academic site management organization that operates within the Duke Health Care
System.
trial was to investigate the efficacy of specific SSRI treatments on depression. As such, the
participants were randomly assigned particular drug treatments and followed over time. The
data set has the unique feature that it follows individuals over time. The decision to begin
antidepressant therapy was based solely on the primary care provider’s (PCP) judgment that
the patient’s depression warranted antidepressant therapy.3 Once the individual qualified for
the study, a touch tone telephone procedure was used to randomly assign the patient to a spe-
cific antidepressant.4 Both patients and PCP’s were aware of the SSRI assignment. Decisions
regarding treatment changes, including SSRI type, dosage, and discontinuation were allowed
and jointly made by the patient and the PCP.5 Patients received a pharmacy benefits card
covering the costs for the SSRI and any non-SSRI antidepressant that the PCP prescribed
during the study.6 Study patients also received payments as reimbursement for their time.
Participants received $20 for each completed telephone interview, with additional payments
of $20 for 4 completed interviews and $30 for 5 completed interviews. A participant of all 5
interviews received a maximum of $150.
Computer assisted telephone interviews were used to assess outcomes. Interviewers did
not divert from the interview format and were required to use preselected response options.
Certain follow-up interviews were not complete. In order to get complete data, in the cases
where individuals were difficult to reach, a prioritized list of questions was used, with the
main outcome being asked first. The participants were considered still participating even if
the interview was incomplete. They may have also been included in a later wave even if they
were missing from a previous wave.
3The trial was set up to resemble real world practice and the practitioners did not receive additional training
that could potentially change typical treatment patterns.
4The possible antidepressants were either 20 of mg paroxetine (Paxil), 20 mg of fluoxetine hydrochloride
(Prozac), or 50 mg of sertraline (Zoloft).
5It is important to note that the decision to begin antidepressant therapy was based solely on the PCP’s
judgement that the patient’s depression warranted antidepressant therapy. Using HSCL categories, approxi-
mately 6.67% of the sample individuals are categorized in the ‘depression in remission’ group at baseline.
6Providing the card minimized differences in patient compliance that could be due to socioeconomic factors.
Antidepressant drugs covered by the card included: Amitriptyline chlordiazepoxide, Amitriptyline hydrochlo-
ride, Amitriptyline hydrochloride/perphenazine, Amoxapine, Bupropion hydrochloride, Citalopram hydrobro-
mide, Clomipramine hydrochloride, Desipramine hydrochloride, Doxepin hydrochloride, Fluoxetine hydrochlo-
ride, Fluvoxamine maleate, Imipramine hydrochloride, Imipramine pamoate, Maprotiline hydrochloride, Mir-
tazapine, Nefazodone hydrochloride, Nortriptyline hydrochloride, Paroxetine hydrochloride, Phenelzine sul-
fate, Protriptyline hydrochloride, Sertraline hydrochloride, Tranylcypromine sulfate, Trazodone hydrochloride,
Trimipramine maleate, and Venlafaxine hydrochloride.
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These data have the limitation of following only those initially diagnosed as depressed,
making selection an issue. Additional limitations include the patient self-reporting on therapy
compliance and the fact that the treating physicians were not privileged to outcome infor-
mation from the telephone interviews.7 601 patients provided informed consent and were
randomized to treatment. 573 of these individuals completed the baseline telephone assess-
ment. The survey consists of a baseline interview and 4 follow-up interviews in varying time
intervals. Follow-up phone interviews were successfully completed for 79% of the participants
at 9 months. Table 3.1 below details participation and follow-up of the original sample.
Table 3.1: Number of Patients at each interview
Baseline Interview 573 patients
At least 1 follow up interview 546 patients
1 month interview 538 patients
3 month interview 504 patients
6 month interview 483 patients
9 month interview 455 patients
Table 3.2 details availability of data in each interview, where 10111, for example, indicates
that the participant missed the second interview. Note that I drop individuals aged 65 and
older due to retirement possibilities, those with ages 18-22 due to schooling possibilities and
one individual with no age information from the sample. Other individuals with missing
employment information were also dropped from the sample. Statistics reported from here
on are based on the 315 individuals with complete information for all interviews. These data
provide 1575 observations for analysis.
3.2 Health Variables and Scales
It is important to consider different issues in the measurement of mental illness. In the
mental health and labor literature, different strategies are used. One common approach is the
7This was to resemble real work practice.
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Table 3.2: Individual Participation Patterns over the 5 interviews
Pattern Longest Number of
Spell Individuals
01110 3 1
01111 4 2
10000 1 24
10100 1 2
10101 1 1
10110 2 1
10111 3 3
11000 2 20
11010 2 5
11011 2 12
11100 3 15
11101 3 15
11110 4 34
11111 5 315
total 450
utilization-based approach (Frank and Gertler, 1991). With this method, the individuals are
asked if they have ever been treated for a mental disorder. If they answer yes, they are asked
to identify the diagnosed disorder. With another approach, individuals are asked varying
questions about their mental health status. They characterize each element as excellent,
good, fair or poor. A more recent approach utilizes symptoms and clinical algorithms to
determine diagnoses. Individuals respond to questionnaires that identify clinical symptoms.
These symptoms either directly indicate a mental health problem or are used in algorithms
to determine a diagnosis. Specifically, the diagnosis of major depressive disorder is based on
the patient’s self-reported experiences, behavior reported by relatives or friends, and a mental
status exam. There is no laboratory test for major depression.
The ARTIST trial consists of multiple scales that can be used to measure depression
and/or physical health: The Depression Diagnosis Interview Questions (DDI), The Hopkins
Symptom Checklist (HSCL), The Physical Symptoms Scale (PSS), The 9-item Patient Health
Questionnaire (PHQ-9), The 36-item Short-Form Health Survey (SF-36) and The 12-item
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Short-Form Health Survey (SF-12).8 Each scale has specific benefits and shortcomings. There
is an SF-12 score for each interview. SF-36 is only used at baseline and in months 3 and 9. The
DDI questions are also only asked at baseline, and in months 3 and 9. Depression outcome
is assessed with two measures of core depressive symptoms, the HSCL-209 and SF-12 mental
health component scores. I use both the HSCL-20 mental health component score and SF-12
mental health component scores as measures of depression in this paper. Both are validated
measures of depression severity.
Depression severity is often defined as mild, moderate or severe. The levels are described
in terms of the extent to which the patient’s everyday life is affected: mild depression causes
only minor impairment of the patient’s work, social life and relationships with others. Major
depression, as defined in the DSM-IV, can be of mild severity. Moderate depression is as-
sociated with more obvious symptoms and is more likely to be noticeable to others. Severe
depression is characterized by affecting the patient so badly that he or she may be unable to
work or to relate socially to others. Full remission is defined as the absence of symptoms for
at least two months. For partial remission, full criteria for a major depressive episode are no
longer met, or there are no substantial symptoms, but two months have not yet passed. In
this study, I do not distinguish between full and partial remission.
HCSL-20
The Hopkins Symptom Checklist (HSCL) is a self report symptom inventory originally
comprised of 58 items representing symptoms commonly observed in outpatients. There
are five underlying symptom dimensions: somatization, obsessive-compulsive, interpersonal
sensitivity, anxiety and depression. The original 58-item symptom inventory expanded to
incorporate 32 additional items in four symptom dimensions: hostility, phobic anxiety, para-
noid ideation and psychoticism. The HSCL-20 is a 20-item modified subscale of the 90-item
Hopkins Symptom Checklist. The scores range from 0-4 with a higher score indicating a more
8SF-36 and SF-12 are versions of the same scale.
9The HSCL-20 is a 20-item modified subscale of the 90-item Hopkins Symptom Checklist. The 20-item
scale includes the full 13-item depression subscale of these longer instruments plus 7 additional items that
allow for an assessment of all Diagnostic and Statistical Manual, fourth edition (DSM-IV) items. Using these
scales, an HSCL-20 mean score is calculated for each individual in each time period.
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serious depressive episode. This continuous variable will be used in all estimations. To serve
as a frame of reference, the scores are divided into 4 categories, each representing a different
degree of depression.
HSCLt =

1 depression in remission: 0.00 ≤ HSCLt < 0.75
2 mild depression: 0.75 ≤ HSCLt < 1.50
3 moderate depression: 1.50 ≤ HSCLt < 2.00
4 severe depression: 2.00 ≤ HSCLt ≤ 4.00
(3.1)
Table 3.3: Summary of Depression using HSCL-20 Score
Month Obs Mean SD Min Max
all 1575 1.05 0.73 0 3.20
Baseline 315 1.68 0.66 0.2 3.15
1 315 1.07 0.64 0 3.20
3 315 0.90 0.66 0 3.20
6 315 0.84 0.66 0 3.20
9 315 0.76 0.63 0 2.85
As seen in Table 3.3, the HSCL-20 mean measure continues to decrease throughout the
ARTIST trial, meaning that the patients’ general depression levels continuously improve. It
decreases at a decreasing rate until the last period with the largest improvement occurring in
the first period with a 36.30% change.
The trial follows individuals over time, and it is important to consider the breakdown of
the variation in the depression score into between-individual variation and within-individual
variation. I report similar statistics for the remainder of the outcome variables. Refer to
Table 3.4. Overall, 39.62% of the person-year observations are considered to be in remission
and 13.90% are categorized as having severe depression. Taking patients individually, 71.11%
of the individuals are in remission at some point, with 39.68% considered to be severely
depressed at least once; thus some individuals are characterized as having severe depressive
symptoms at one interview but not at others. Taking one individual at a time, if an individual
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is considered to have major depression at least once, 35.04% of her observations fall into the
severe depression category. Similarly, if the patient is ever categorized to be in remission,
55.71% of her observations are considered to be in remission. If an individual’s depressive
status never varied over time in these data, the within individual variation percentages would
all be equal to 100. With a continuous variable, the mean and decomposed standard deviation
are reported. The standard deviation is decomposed into between and within components. If
the within standard deviation is equal to 0, all of the variation is between individuals. The
0.50 for the within variation confirms that there is variation within the individual.
Table 3.4: Variation in HSCL-20 Mental Health Variable
Variable Mean SD Min Max Obs
HSCL-20 Score
overall 1.05 0.73 00.00 3.20 N = 1575
between 0.53 00.09 2.78 n = 315
within 0.50 -0.54 3.11 T-bar = 5
Overall(%) Between (%) Within(%)
HSCL-20 category (n=315)
in remission 39.62 71.11 55.71
mild depression 32.57 78.73 41.37
moderate depression 13.90 46.35 30.00
severe depression 13.90 39.68 35.04
SF-36 and SF-12
The 36-item Short-form Health Survey (SF-36) measures health-related quality of life
in eight domains, including physical functioning, social functioning, mental health, general
health perception, pain, vitality, and physical and emotional role functioning. Selected mea-
sures from the Medical Outcomes Study (MOS) are also used to assess social functioning,
concentration, positive well-being, hopefulness, sleep, and sexual function. Anxiety and al-
cohol disorder items are taken from the PHQ-9. Additionally, questionnaires were used to
evaluate quality of close relationships and disposition.
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The 36-item short form was constructed to survey health status in the Medical Outcomes
Study (MOS), which was a part of the phone interviews at baseline, in month 3 and in
month 9. The SF-36 was designed for use in clinical practice and research, health policy
evaluations, and general population surveys. It includes one multi-item scale that assesses
aspects of both the individual’s physical and mental health: limitations in physical activities
because of health problems, limitations in social activities because of physical or emotional
problems, limitations in usual role activities because of physical health problems, bodily pain,
general mental health (psychological distress and well being), limitations in usual role activity
because of emotional problems, vitality (energy and fatigue), and general health perceptions.
Since this study is primarily concerned with questions surrounding mental health issues, I
will describe the questions that pertain to mental health. The 14 questions, out of 36 total
questions, affecting mental health fall into one of four scales (Vitality, Social Functioning,
Role- Emotional, Mental Health). The questions, scales and response alternatives that affect
the SF-36 score are found in Appendix A. The scores range from 0 to 100, with higher scores
indicating better mental health. As summarized in The SF-36 physical and mental health
summary scales: A user’s manual the best cut off for defining depression using the SF-36
mental health component score is at a score of 42.00 or below. This score minimizes the
possibility of either a false negative or a false positive. The false positive rate using this
SF-36 mental component scale cutpoint is 19.40% and the false negative rate is 26.30%.
The SF-12 was developed to be a much shorter, yet useful, alternative to the SF-36.
Only one to two questions are asked for each of the four scales (Vitality, Role Emotional,
Social Functioning, and Mental Health) rather than the three to four questions in the SF-
36. The choice between the 36-item or 12-item versions is largely practical and each has
advantages. The SF-12 is much shorter while reproducing the SF-36 summary scales very
well. It has the advantage of maximizing participant retention. The SF-36 profile has the
advantage of providing more information about the nature of differences in physical and
mental health outcomes. The SF-12 also uses a composite score of 42.0 as the cutoff score for
defining depression. The SF-12 interview is calculated in each month of the ARTIST trial.
At baseline, and in months 3 and 9, there are SF-12 and SF-36 scores for each individual.
16
In months 1 and 6, only twelve questions are asked so there is only a SF-12 score for each
individual interviewed in these months. The SF-12 scores will be used to divide the sample
into nondepressed and depressed individuals.
Table 3.5: Summary of Depression using SF-12 Score
Month Obs Mean SD Min Max
all 1575 44.04 12.06 4.45 65.83
Baseline 315 32.48 10.91 4.45 61.68
1 315 43.83 10.63 9.10 65.84
3 315 47.13 10.86 9.82 65.20
6 315 47.49 10.01 13.68 64.11
9 315 49.26 9.79 16.81 64.91
Similarly to when using the HSCL-20 component score, the SF-12 measure of mental
health continuously improves throughout the ARTIST trial as reported in Table 3.5, with a
higher score indicating better mental health. Patients experienced improvement each period,
with the largest improvement occurring in the first period with a 34.94% change. In Table 3.6,
it can be seen that there is within-individual variation for the SF-12 mental health measure
variation (SD=8.98).
Table 3.6: Variation in SF-12 Mental Health Variable
Variable Mean SD Min Max Obs
SF-12 Score
overall 44.04 12.06 4.45 65.83 N = 1575
between 8.06 15.26 61.78 n = 315
within 8.98 9.60 72.64 T-bar = 5
The SF-12 also includes questions related to physical health. The Physical Symptoms
Scale (PCS-12) is a scale consisting questions regarding the patient’s physical health. The
scores range from 0 to 100, with higher scores indicating better physical health. These
questions are asked at each interview. See Appendix B for the list of questions.
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It can be assumed that any chronic condition will affect all decisions and outcomes in the
model. As a measure of medical comorbidity, I will use the Chronic Disease Score (CDS)
which is calculated at baseline for each patient. The CDS score increases with the number
of different chronic diseases as inferred from the subject’s medication profile. At baseline,
each patient is asked to list up to 14 prescription medications she is currently taking. With
these responses, the CDS score is calculated and used as a comorbidity index.10 Scores
have been shown to predict mortality and health care resource utilization after controlling
for demographics and previous resource utilization.11 As a measure of chronic depression,
at baseline, participants are asked if they had ever been treated for depression prior to the
ARTIST study. 34.60% of the individuals had experienced a depressive episode prior to the
ARTIST study. Baseline characteristics of these individuals are provided in Table 3.7.
Table 3.7: Baseline Health Characteristics of Sample
Baseline Characteristic Mean SD
Mental Health HSCL-20 score 1.68 0 .66
Mental Health HSCL-20 category (%)
in remission 6.67
mild depression 32.06
moderate depression 25.71
severe depression 35.56
Mental Health SF-12 score 32.48 10.91
Physical Health SF-12 score 49.94 9.79
Chronic Disease Score 1.62 2.08
Past history of depression (%) 34.60
3.3 Labor Variables
The indirect costs related to depression can come in the form of presenteeism or absen-
teeism. The probability of being employed is also affected. This study uses three categories
of labor variables: participation variables (whether or not the individual is employed); absen-
10Specific medications are assigned to medication classes, which are then mapped to different chronic diseases.
11The CDS score employs empirical weights.
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teeism variables (conditional on being employed, how often the worker is absent from work);
and presenteeism variables (conditional on employment, the worker’s productivity while at
work).
Work Limitations Questionnaire-Presenteeism and Absenteeism Variables
The Work Limitations Questionnaire (WLQ) labor variables are only used if the individual
answers yes to the following question: In the past two weeks did you work at anytime at a
job or business not counting work around the house?12
The objective of the WLQ was to develop a psychometrically sound questionnaire for
measuring the impact of chronic health problems and/or treatment on different job aspects of
employed workers. The WLQ is a self-reported instrument for measuring the degree to which
chronic health problems interfere with a workers’ ability to perform job roles with four dis-
tinct dimensions: handling time, physical, mental-interpersonal, and output demands. With
25 items, and a 2-week reporting period, the Work Limitations Questionnaire demonstrates
high reliability and validity. Unlike other questionnaires it addresses aspects of the job through
a demand-level methodology. In comparison to other questionnaires, the WLQ Output De-
mands scale, which I use to measure presenteeism, has superior performance for predicting
productivity. The Mental Interpersonal Demands and the SF-36 Role Limitation scales, which
are not used in this study, have moderate validity.13 A full listing of the questions can be
found in Appendix C.
Tables 3.8 and 3.9 report between-individual and within-individual variation for the labor
variables. In Table 3.8 it can be seen that there is within-individual variation in both the
employment probability measure and the ability to meet the required number of work hours.
Table 3.9 reports means and standard deviations of the productivity measure for the overall
sample, between-individual and within-individual. The within statistics show the variation
of the ability to meet output demands within person around the global mean 74.62. The
within-individual SD shows that there is also within- individual variation in the productivity
12The wording of this question limits its use as an indicator of employment. An individual may still be
employed if he/she has not worked in the last two weeks due to vacation, maternity leave, or an illness.
13For a full discussion of validity tests, see Lerner et al., 2002.
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measure.
Table 3.8: Variation in Labor Variables
Overall(%) Between (%) Within(%)
Employment Probability (n=315)
does work 74.22 86.98 85.33
does not work 25.78 46.98 54.86
Ability to Meet Required Work Hours (n=274)
All of the time 56.29 86.50 62.91
Most of the time 20.19 54.38 35.33
Some of the time 16.42 44.53 34.85
A slight bit of the time 6.07 19.34 30.74
None of the time 1.03 4.38 24.00
Table 3.9: Variation in Productivity Measure
Variable Mean SD Min Max Obs
Productivity
overall 74.62 19.46 5 100 N=1169
between 15.39 26 100 n=274
within 12.12 26.18 115.62 T=4.26
Table 3.10 presents descriptives statistics for each labor outcome by depressive state.
As expected the less depressed samples perform better for all labor variables. Employment
probabilities and depression levels show an inverse relationship, with 74.22% of the remission
sample being employed and only 67.00% of the sample categorized as having severe depression
working outside of the home. As depression levels decrease, the probability of working con-
tinuously increases. Less depressed workers are also better able to work the required number
of work hours. Again we see that the largest difference can be found between the depression
in remission sample and the mild depression group. The productivity measure also shows
less desired outcomes for more depressed individuals. It can be seen that the difference in
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productivity between the remission sample and those classified as having major depression is
larger than when comparing the sample’s employment probabilities and absenteeism.
Table 3.10: Summary of Labor Variables by HSCL-20 Mental Health Category
Variable n Mean SD Min Max
Employment Probability
full sample 1575 0.74 0.43 0 1
severe depression 219 0.67 0.47 0 1
moderate depression 219 0.72 0.44 0 1
mild depression 513 0.73 0.44 0 1
in remission 624 0.78 0.41 0 1
Ability to Meet Required Hours at Work
full sample 1169 4.24 1.00 1 5
severe depression 147 3.26 1.14 1 5
moderate depression 159 3.74 1.05 1 5
mild depression 376 4.22 0.92 1 5
in remission 487 4.72 0.61 1 5
Productivity
full sample 1169 74.62 19.46 5 100
severe depression 147 51.79 19.11 5 100
moderate depression 159 62.62 18.32 10 100
mild depression 376 73.11 16.25 5 100
in remission 487 86.60 11.73 35 100
3.4 Treatment Variables
At baseline, a touch tone telephone procedure was used to randomly assign the patient to a
specific antidepressant: either Prozac, Zoloft or Paxil. A variable to indicate initial assignment
is created for each individual. Prior to randomization, the PCP is asked what antidepressant
he would prescribe in the absence of randomization. Responses included Celexa, Paxil, Prozac,
Wellbutrin, Zoloft or NA.14 These variables are summarized in Table 3.11.
A variable indicating if the same drug the PCP would have prescribed was randomized
14N/A indicates that the PCP’s response was not Celexa, Paxil, Prozac, Wellbutrin or Zoloft.
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to the patient at baseline is defined for each individual.15 Both patients and PCP’s were
aware of the baseline SSRI assignment. Decisions regarding treatment changes, including
SSRI type, dosage, and discontinuation were allowed and jointly made by the patient and
the PCP. At each interview, the individual is asked about her treatment decisions. She may
choose between continuing on the current drug, immediately switching to a new drug or
discontinuing use of the current drug without switching to an alternate medication. If she
chooses to change medication type, she is asked what type of SSRI she is currently taking.
At the next interview, she is asked about her treatment decisions with respect to the new
drug. 61% of the patients remain on the randomized drug throughout the trial. 20% of the
sample eventually stops the randomly assigned medication and does not immediately switch
to a new drug within the survey period, while 19% change SSRI medication and immediately
switch to a different SSRI at least once.
Table 3.11: Treatment Variables
Treatment Variable %
Randomized Drug
Prozac 32.38
Paxil 32.38
Zoloft 35.24
PCP Preferred Drug
Prozac 27.62
Paxil 22.22
Zoloft 26.98
other 23.18
Same Drug Randomized & Prescribed 33.33
15If the PCP would have prescribed Celexa, Wellbutrin or another antidepressant, this value is automatically
equal to 0. These common responses, Celexa and Wellbutrin, are each in another class of antidepressants (not
SSRI).
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3.5 Exogenous Variables
Exogenous variables include the individual’s age, gender and race. Baseline characteristics
of the sample are found in Table 3.12. Additional time-varying information that may affect
outcomes exogenously are available from other data sources. Although participants report five
digit zip code information at each interview, Zip Code Tabulation Areas (ZCTAs) are used for
extracting Census 2000 and Current Population Study (CPS) information on a geographic
area from the reported zip code.16 Monthly state unemployment rates from the Current
Population Study (CPS) are also used in the estimations. 21 states and Washington D.C.
are represented in the study. Table 3.13 describes the sample by state distribution. Current
local economic conditions facing the individual are likely to affect all employment decisions.
Therefore, they will be included in all labor equations.
Table 3.12: Summary of Baseline Individual Exogenous Characteristics
Baseline Characteristic
Age 43.84
(9.89)
Age Range 23-64
Women % 80.95
Race %
White 84.13
Black 13.65
Other 2.22
The month of the year is also included as a time-varying explanatory variable. The
calendar month of the year may affect both labor and health outcomes. Individuals may
experience more mental and physical health problems during the winter months. It is also
possible that labor outcomes may differ during specific times of the year. For example, a
worker may be more likely to take vacation during the summer months or during the winter
holiday time. Productivity may also be affected during specific times of the year depending
on the worker’s industry. Individuals enrolled in the study and completed baseline interviews
16See Appendix E for discussion of ZCTAs.
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Table 3.13: Represented States
State Person-months % of sample
North Carolina 648 41.14
Georgia 160 10.16
Pennsylvania 130 8.25
Missouri 82 5.21
California 70 4.44
Maryland 47 2.98
New York 65 4.13
Ohio 70 4.44
Texas 50 3.17
Florida 45 2.86
Arizona 45 2.86
Iowa 40 2.54
Michigan 45 2.86
Illinois 18 1.14
Indiana 15 0.95
Virginia 15 0.95
Tennessee 10 0.63
Oklahoma 5 0.32
Washington D.C. 5 0.32
South Carolina 5 0.32
Wisconsin 5 0.32
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during different months. On the interview date I create indicator variables=1 for each of the
twelve months.
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Chapter 4
Theoretical Motivation
This section includes the theoretical background to the paper. In Section 5, I describe an
empirical approximation to the theoretical model that follows.
4.1 Overview of Decision Making Process
The individual enters a decision making period t knowing her employment history, current
health status and her mental and physical health history. Future mental and physical health
are uncertain. With this knowledge, she decides whether or not to work in period t. By
accepting employment, she contracts for a certain number of hours of required work hours
(full time or part time). The required work hours are unobserved by the econometrician.
Conditional on working, the individual then decides the number of these required hours to
work and how productive to be for the duration of period t. The individual must also decide
whether to continue her current medication, switch to another medication or discontinue
medication treatment entirely. The individual then realizes her health status at the end of
each period t. The per-period timing of decisions and realizations of health are depicted
below.
4.2 Decision Variables
Each period, individuals make optimal decisions with respect to employment and mental
health treatment. At the beginning of time period t, the worker decides whether or not to
beginning
of t
et
employment
decision
ot, at
productivity,
attendance
decisions
Dt
treatment
decision
ht+1, bt+1
health
production
beginning
of t+ 1
St = (et−1, ot−1, at−1, Dt−1, ht, bt
Xt,Zt) -
St+1 = (et, ot, at, Dt, ht+1, bt+1
Xt+1,Zt+1) -
Figure 4.1: Timing of per-period Employment and Treatment Decisions and Health Produc-
tion
work outside of the home (et) where
et =
 0 if individual does not work1 if individual works.
If she decides to accept outside employment, she chooses her level of productivity for the
remainder of the period (ot) and attendance (at). The productivity measure (ot), a self
reported ability to meet output demands, takes the value 0 to 100, with 100 indicating
the highest productivity. With regard to absenteeism, the respondents answer the following
question: “Conditional on working, how much of the time during the past two weeks did your
physical health or emotional problems make it difficult for you to work the required number
of hours?” Attendance (at) takes on the values (with a higher score indicating less limitation):
at =

1 All of the time
2 Most of the time
3 Some of the time
4 A slight bit of the time
5 None of the time
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The individual makes the medication treatment decision (Dt). Treatment options include:
Dt =

0 if patient continues on the same drug
1 if patient immediately switches from the current drug to another drug
2 if patient stops current drug, does not immediately switch to new drug
When making decisions in period t, the individual may consider her employment status
(et−1), her productivity (ot−1), and her attendance at work (at−1) in the previous period.
She also considers her wage offer which depends on the worker’s employment history and past
performance. The wage offer is unobserved by the researcher.
Decisions may also be influenced by the individual’s health history including her treatment
decisions in the previous period (Dt−1), mental health state entering the current period (ht)1
where
ht =

1 if depression in remission
2 if mildly depressed
3 if moderately depressed
4 if severe depression
and physical health entering the current period (bt) where bt scores range from 0 to 100 with
higher scores indicating better physical health.
Current economic conditions such as median income by zipcode and monthly state un-
employment rates may also influence labor decisions and are denoted by the vector Zt. All
decisions are influenced by observed personal characteristics, Xt, including gender, race, and
age. The individual’s information, or state vector(St), entering period t is:
St = (et−1, ot−1, at−1, Dt−1, ht, bt, Zt, Xt). (4.1)
1In the empirical estimation different linear and categorical scales for mental health are used.
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4.3 Health Production
An important part of this study is understanding how mental health evolves. The mental
health production function, or probability of a health transition from ht = h to ht+1 = h′, is
modeled as
pihh
′
t+1 = Pr(ht+1 = h
′ | ht = h) ∀t
= exp {pi0h′+pi1h′ht+pi2h′St+1}P4
h′′=1 exp {pi0h′′+pi1h′′ht+pi2h′′St+1}
. (4.2)
Particular components of St+1, namely (et, ot, at, Dt, bt+1, Xt+1), may influence depression.
Physical health (bt) also develops based on decisions and observed characteristics where
bt+1 = b(bt, ht, St+1). (4.3)
4.4 Optimization
An individual’s per period utility is a function of consumption (Ct), mental health status
(ht), labor choices (et, at, ot) and treatment decisions (Dt). Let J equal the set of combinations
of the et, at, ot and Dt alternatives available to an individual. Each unique combination is
denoted j, j=1,2,3...J. Health status is assumed to have both direct effects (i.e., healthier
individuals derive more utility in all activities) and indirect effects (through its effect on
labor and treatment decisions) on utility. Treatment decisions affect utility through the
medication’s effects on physical health (side effects) and have productive effects on mental
health status. The individual’s per-period alternative-specific utility function is given by
U jt = U(j, Ct, ht, bt, Xt, ε
j
t ) (4.4)
where εjt represents alternate-specific and time-specific unobserved utility preferences and
consumption (Ct) is constrained by her budget. Sources of income include employment income
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(Yt) if employed (et = 1) and unearned income (Wt) such that
Ct = et ∗ Yt +Wt. (4.5)
Employment income, Yt = Y (Xt, et−1, at−1, ot−1), is a function of personal characteristics,
and her employment history, days present at work and productivity in period t− 1. If et= 0,
consumption is constrained by unearned income. Treatment for depression is costless in these
data in pecuniary terms but may cause disutility through side effects, discomfort or stigma.
An individual is assumed to make decisions that will maximize her expected lifetime
utility. This includes the current utility of each alternative plus the discounted present value
of expected future utility where health and future utility shocks are uncertain. Her lifetime
value of each employment and treatment alternative is:
Vj(St, t) = U
j
t +
4∑
h′=1
pihh
′
t+1Et
[
max
k∈J
Vk(St+1, kt+1) | j
]}
∀j ∀t (4.6)
where β is the discount factor. Since this research focuses on mental health and its effects
on labor market outcomes, physical health transitions are not modeled explicitly in the value
function. While physical health develops overtime, the value function assumes as written that
physical health is exogenous and known with perfect foresight.
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Chapter 5
Empirical Model
In measuring the effect of mental health on labor outcomes, many studies use the human
capital framework (Becker 1967, Grossman 1972) and assume people value good health for
both its direct effect on utility and its effect on human capital formulation. This paper focuses
on the relationship between depression and different labor market outcomes. Underlying the
analysis is the idea that for a group of depressed individuals, changes in depression levels lead
to changes in labor market outcomes. Additionally, treatment decisions affect health status.
In measuring the effects of depression on productivity and attendance for a group of initially
depressed individuals, there are multiple sources of bias that must be addressed in order to
obtain consistent estimates.
Two sources of endogeneity can lead to biased estimates of depression’s effect on labor
market outcomes. Structural endogeneity results from possible reverse causality. In this case,
the onset of depression may occur due to labor market outcomes. Statistical endogeneity
comes from potential unobserved factors causing depression that may also affect labor market
outcomes independent of depression. For example, unobserved personal characteristics, such
as excessive motivation or employment in high stress occupations may increase the risk of
depression and can lead to different labor outcomes. Including treatment decisions variables
explaining mental health transitions introduces additional potential bias in the measured
effect. Potential endogeneity results from permanent unobserved characteristics that affect
both the individual’s mental health status and treatment decisions.
In this dynamic model, the labor outcomes Lt are the individual’s log productivity at
work ot and attendance at, (Lit = [oit, ait]) if employed. The relationship is dynamic because
an individual’s labor outcomes depend on lagged endogenous variables. Let
eit =
 1 if individual works in period t0 if individual does not work in period t.
The work productivity (oit) and work attendance (ait) measures are only observed if the
individual works in period t (eit = 1). This dynamic model of labor outcomes includes a
lagged dependent variable as a regressor as follows:
Lit = δLi,t−1 + αTi + βXit + εit if eit = 1. (5.1)
An individual’s labor outcome Lit is related to time-invariant personal characteristics Ti1, a
vector of time-varying observables for the individual, Xit, and a disturbance term, εit. The
error component εit is decomposed as
εit = µi + νit (5.2)
where µi represents unobserved time invariant personal characteristics that will affect labor
outcomes (such as genetics) and νit accounts for random individual disturbances (such as
time-varying work demands). The vector of disturbances νit is assumed to be independent
and identically distributed (IID) IID(0, σ2ν) and µi is distributed IID(0, σ
2
µ). Substituting
equation (5.2) into equation (5.1),
Lit = δLi,t−1 + αTi + βXit + µi + νit if eit = 1. (5.3)
The binary choice selection model explaining whether an individual is working is described
by
e∗it = ωΓit + ηi + ζit. (5.4)
1Ti is not included in the theoretical model in the previous section. I separate this to clearly show the
effects of purging the model of the time-invariant individual effect.
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where
eit =
 1 if e
∗
it > 0
0 if e∗it ≤ 0
Γit is a vector of explanatory variables that may share elements with Xit, ηi is an un-
observable time-invariant individual-specific effect and ζit represents unobserved individual
time-specific disturbances. It is assumed that the error components in the two equations have
a joint normal distribution. This selection equation must be estimated jointly with the labor
outcomes in order to eliminate selection bias.
Dynamic panel bias and selection bias are additional sources of potential bias. Introducing
a lagged dependent variable complicates estimation when compared to a static model because
labor outcomes in past periods may also be correlated with unobserved permanent individual
heterogeneity, E(Li,t−1, µi) 6= 0. Sample selection bias refers to problems where the dependent
variable is observed only for a restricted, nonrandom sample. In this case, the individuals
productivity in period t is only observed if the individual is employed in that period. Similarly
to the productivity equation (the equation of interest), the employment equation (the selection
equation) may contain individual specific effects that are correlated with the explanatory
variables. To obtain consistent estimates, all potential sources of bias must be addressed.
In this study, the employment of an individual depends on unobserved time-invariant char-
acteristics of the individual such as motivation, ability or education level, E(eitµi) 6= 0. These
characteristics are correlated with the unobserved individual effects from the productivity and
attendance equations.
If the potential sources of bias are due to time-invariant characteristics, a researcher can
time difference the data then use instrumental variables (IV) in a Generalized Method of
Moments (GMM) framework. The First-Differenced (FD) equation is:
(Lit − Li,t−1) = δ(Li,t−1 − Li,t−2) + β(Xit −Xi,t−1) + νit − νi,t−1. (5.5)
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This is equivalent to
∆Lit = δ∆Li,t−1 + β∆Xit + ∆νit. (5.6)
If the selection process is time constant, removing the fixed effect from productivity or at-
tendance equations eliminates any potential selection problem operating through µi. Now,
selection into employment is random when unrelated to the idiosyncratic errors νit, (i.e.,
E(eitνit) = 0). Since T = 5 and the entire panel covers 9 months, this is a realistic assump-
tion. For consistency, it is required that
E[∆νit|Xit, Xis, eit = eis = 1] = 0 ∀ s < t. (5.7)
First-differencing has the advantage that it eliminates the individual specific effects that are
correlated with both the explanatory variables in the labor equation and the selection equa-
tion. However, it does have an important weakness when an individual is not employed in
period t, eit 6= 1 ∀ t, since there is a gap in the panel.2 In these instances, there are no
productivity measures for these observations and with T = 5, many needed observations are
lost. A second transformation that will eliminate fixed effects without losing as many obser-
vations is called forward orthogonal deviations (FOD) (Arellano and Bover, 1995). Rather
than taking first-differences as in equation (5.5), it subtracts the average of all future available
observations of a variable. Therefore, despite the number of gaps, it can be computed for all
observations of Lit and explanatory variables except for t = 5. The orthogonal deviations
transform for any variable w is:
wi,t+1 ≡ cit
(
wit − 1
Tit
∑
s>t
wis
)
(5.8)
where Tit is the number of all future available observations. The scale factor to equalize the
variance of the transformed error, cit, equals
√
Tit/(Tit + 1). With this transformation, the
disturbance term becomes
ν∗i,t+1 ≡ cit
(
νit − 1
Tit
∑
s>t
νis
)
. (5.9)
2When some value of Lit is missing, then both ∆Li,t+1 and ∆Lit are missing when first-differenced.
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Again, individual specific effects are removed. Additionally, Arellano and Honore (2001)
note that using orthogonal deviations does not introduce a moving average process into the
disturbance. The time-invariant individual effect is purged, but νi,t−1 is now correlated with
Li,t−1, E(Li,t−1, νi,t−1) 6= 0 and any other lagged endogenous variables. Thus, Ordinary Least
Squares (OLS) produces inconsistent estimates. However, instruments for ∆Li,t−1 and other
lagged endogenous covariates can be used since they are uncorrelated with the error term.
Estimation
For comparison purposes, I first estimate the equation of interest using ordinary least
squares. I pool the data and estimate an OLS regression,
Lit = δLi,t−1 + αTi + βXit + εit if eit = 1. (5.10)
OLS estimates are biased due to dynamic panel bias, sample selection bias and unobserved
heterogeneity. Standard results indicate that the OLS levels estimator is biased upwards by
attributing unobserved characteristics in the individual’s fixed effect to endogenous covariates.
In the model, it is probable that both the time-varying and time-invariant explanatory
variables are correlated with an individual’s unobserved characteristics. It is realistic to
suspect that mental health, the variable of primary interest, is endogenous, E(Xitµi) 6= 0. A
time-invariant observed characteristic, such as whether or not the individual had ever been
treated for depression before the study, is likely endogenous as well, E(Tiµi 6= 0).
The fixed effects (FE) approach allows for the fact that an error term for a specific indi-
vidual will be correlated over time. Fixed effects estimates are also included for comparison
purposes. As µi is constant over time within-individuals, differing only between units, this
approach eliminates µi from the equation by measuring the deviation of each variable from
the within-individual mean of the variables. Time-constant unobserved heterogeneity is no
longer a problem. Averaging equation (5.3) over time gives
L¯i = δL¯i,t−1 + αTi + βX¯i + µi + ν¯i. (5.11)
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Subtracting equation (5.11) from equation (5.3), µi, the individual error component, and Ti,
the vector of constant explanatory variables, are purged from the equation leaving
(Lit − L¯i) = δ(Li,t−1 − L¯i) + β(Xit − X¯i) + νit − ν¯i. (5.12)
After removing the individual effect from the equation, applying the standard least squares
estimator to the deviations gives the covariance estimator of β. Intuitively, fixed effects
estimators are assuming that each individual has her own intercept (individuals have different
time-invariant characteristics) but each individual’s regression between labor outcome and
regressor will have the same slope. In this study, it is assuming that each person is different,
but a change in mental health status will affect each individual’s labor outcomes the same. The
fixed effects estimator removes the bias resulting from unobserved heterogeneity. However,
it does not correct for dynamic panel bias. The estimator proves to be biased downwards in
standard results. Bond (2002) points out that good estimates of δ should lie in the range
between the OLS and the FE estimates, thus providing a useful check on results.
The lagged labor variable Li,t−1 and other variables in Xit may be endogenous. To correct
for the dynamic panel bias, instruments for ∆Li,t−1 and other lagged endogenous covariates
must be used since they are uncorrelated with the error term. If no exogenous time-varying
instruments are readily available, lags of endogenous regressors can be used to instrument
∆Li,t−1 and ∆Xit in equation (5.6). Anderson and Hsiao (1981, 1982) note that ∆Li,t−2
and Li,t−2 are correlated with ∆Li,t−1, but not with ∆νit, making it a valid instrument for
∆Li,t−1. They propose two instrumental variables estimators of δ that are consistent:
δˆIV 1 =
∑N
i=1
∑T
t=1(Lit − Li,t−1)(Li,t−2 − Li,t−3)∑N
i=1
∑T
t=1(Li,t−1 − Li,t−2)(Li,t−2 − Li,t−3)
(5.13)
and
δˆIV 2 =
∑N
i=1
∑T
t=1(Lit − Li,t−1)Li,t−2∑N
i=1
∑T
t=1(Li,t−1 − Li,t−2)Li,t−2
. (5.14)
The first (equation 5.13) uses ∆Li,t−2 as the instrument and the second (equation 5.14)
uses Li,t−2. Similarly, ∆Xi,t−2 or Xi,t−2 can be instruments for any additional endogenous
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explanatory variables since ∆Xi,t−2 and Xi,t−2 are correlated with ∆Xi,t−1, but not with
∆νit.
Arellano and Bond (1991) report that Anderson-Hsiao estimators are inefficient because
they do not utilize all available instruments. The Generalized Method of Moments (GMM)
estimator uses additional moment restrictions, based on the orthogonality between lagged
values of the dependent variable Lit and the errors νit, thus enlarging the set of instruments.
It is a general estimator designed for dynamic models with the following characteristics:
1. Many individuals and few time periods (“small T , large N”). If T is large, dynamic
panel bias is no longer a significant source of bias.
2. a linear functional relationship
3. a dependent variable that is dynamic
4. independent variables that are not strictly exogenous
5. fixed individual effects
6. heteroskedasticity and autocorrelation within individuals, but not across them.
Arellano and Bond estimators are based on the assumptions that the disturbance term
is mean zero (independent across individuals, and not serially correlated, E(νit) = 0 and
E(νitνis) = 0). Under these assumptions, the transformed residuals from equation (5.6) are
no longer correlated, for all Lit and Xit dated t − 2 and earlier. Now, more instruments are
available to rid the model of the correlation between ∆Li,t−1, ∆Xit and ∆νit in equation
(5.6). With T = 5, the transformed residuals satisfy the following moment conditions (with
Z indicating the instruments):
E(Z ′it∆νit) = 0 ∀ t = 2, 3, 4, 5. (5.15)
For each individual, a system of five equations is denoted
Li = XiΘ + νi
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where
Li =

∆Li3
∆Li4
∆Li5
 , Xi =

∆Li2 ∆Xi3
∆Li3 ∆Xi4
∆Li4 ∆Xi5
 , and νi =

∆νi3
∆νi4
∆νi5
 .
The set of instruments is
Zi =

Zi3 0 0
0 Zi4 0
0 0 Zi5

where Zit = (Li,t−2, Xi,t−2, Li,t−3, Xi,t−3, ..., Li1, Xi1)′ at period t. Rows of the instrument
matrix correspond to the transformed (either by first-differencing or using forward orthogonal
transformation) equations for periods t = 3, 4, 5 for individual i with moment conditions in
equation (5.15). It can be seen that the number of instruments increases as t increases.3
The efficient instrument martrix Zit includes different moment conditions depending upon
whether the explanatory variables are correlated with the fixed effects or not, and whether
they are endogenous, predetermined or exogenous.
Xit may include variables that are considered endogenous in the sense that Xit are corre-
lated with the error term νit and earlier shocks but uncorrelated with νi,t+1 and subsequent
shocks. Endogenous variables are treated symmetrically with the dependent variable and
lagged values Xi,t−2 and longer lags are valid instruments for the transformed equations. If
the Xit are predetermined, they are also uncorrelated with the current disturbances but future
values of these variables are correlated with the error term, E(Xitνis) 6= 0 for s < t and 0
otherwise. Therefore, Xi,t−1 is also a valid instrument because the differenced error in equa-
tion (5.6) includes νi,s−1. For strictly exogenous explanatory variables, E(Xitνisνi,s−1) = 0,
all xis are valid instruments.
The validity of GMM estimates depends on crucial assumptions. The consistency of the
estimators depends on the assumption that there is no second order correlation in the error
term of the transformed equation, E(∆νit∆νi,t−2) = 0 . If the νit are correlated, many of
the instruments will not be valid as the crucial moment conditions in equation (5.15) will no
3See Appendix E for more information about GMM.
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longer hold. I use the Arellano and Bond (1991) test for serial correlation in transformed
errors to test the validity of the instruments and the moment restrictions. I also use Hansen’s
J-test of overidentifying restrictions to test the assumptions on the moment conditions and
assess the model specification.
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Chapter 6
Results
This section presents the results of my analysis. The following is a summary of findings.
Using the HSCL-20 score for mental health, improvements in mental health do have a positive
and significant effect on changes in labor productivity as expected. This is found to be true
using the SF-12 mental health scale as well. When the sample is divided into two samples
by severity of depression at baseline, mental health has a significant effect on productivity
for those categorized as having severe or moderate depression at baseline. For the less de-
pressed individuals at baseline, improvements in mental health do not significantly improve
the worker’s productivity.
Improvements in mental health do not have a significant effect on a worker’s attendance
at work except for with the more depressed sub-sample at baseline. Physical health seems
to be a better predictor of an individual’s attendance at work but this result could be biased
due to endogeneity.
For both presenteeism and attendance equations, I present estimates using OLS, Within-
Groups (WG) estimates and two versions of GMM estimation (one using first differencing to
remove the fixed effect and the second using forward orthogonal deviations). Ordinary least
squares violates many of the assumptions necessary for consistent estimates. However, these
estimates can be used for comparison as it inflates the coefficient for the lagged endogenous
variable. Particularly, OLS inflates the coefficient for the lagged employment outcome by
attributing explanatory power to it rather than an individual’s fixed characteristic such as
genetics. The WG estimates of the lagged dependent variable are biased downwards as this
method does not account for dynamic panel bias. They are included for comparison purposes
also. Bond (2002) points out that unbiased estimates of the true value of the lagged dependent
variable should be less than the OLS estimate and greater than the WG estimate. For each
specification, I compare the estimated coefficient to the OLS and WG estimates.
Since the unobserved individual effects (that are correlated with both the regressors in
the labor equation and the employment equation) are removed through differencing, it is
not possible to estimate the effects of any time-invariant regressors, either exogenous or en-
dogenous. For this reason a quadratic in age and an interaction between age and the female
indicator are included. Month dummies are used in all specifications. Summary statistics for
first-differenced variables are found in Appendix G.
All GMM estimations utilize all available moment conditions. The lagged independent
labor outcome, depression measure, physical health measure, and treatment decisions are
considered predetermined. The strictly exogenous time-varying regressors include the unem-
ployment rate, age-squared, the age-female interaction variable and the calendar month.
6.1 GMM Results
6.1.1 Productivity
The log of the presenteeism measure is used as the dependent variable in all presenteeism
specifications. Table 6.1 includes both OLS in levels and WG estimates for the presenteeism
specification using the HSCL-20 score as the measure for mental health. Mental health is
a significant and negative determinant of work productivity using both methods. The OLS
estimate indicates that a one point increase in mental health score (which indicates worse
health) leads to a 3.50% decrease in the WLQ productivity measure, without accounting
for the fact that there are multiple observations per individual. The within-groups estimate
accounts for the correlation in error terms for a specific individual. The coefficient indicates
that after controlling for the fact that there are multiple observations per individual a one
point increase in depression score results in a 4.70% decrease in the work productivity measure.
For the GMM results, specification tests are discussed before the estimated coefficients.
41
The Hansen statistic tests the null hypothesis that the instruments are valid. Table 6.2
includes estimates of the presenteeism equation with first differences and with forward or-
thogonal deviations to remove the fixed effect. The specification statistics using FD are
found in the left column of the lower panel of Table 6.2. The Hansen test p-value is 0.586,
indicating that the null can not be rejected at the 5% significance level. The Arellano and
Bond AR(2) statistics test the null that there is no second-order serial correlation present,
E(∆νit∆νi,t−2) = 0. Again, the p-value (m2=0.072) is above the 5% significance level critical
value, thus implying that there is no second-order serial correlation present and that the es-
timates are consistent. As expected, first order correlation is present due to first differencing
(m1=0.000). There are 47 total instruments, which is less than the number of observations.
Additionally, the estimate of the parameter on lagged productivity does fall within the de-
sired range determined from the OLS and WG estimates. In the right column of Table 6.2,
the fixed effect is removed using forward orthogonal deviations rather than first differencing.
Again, no second serial correlation is present (m2=0.051) and the instruments are determined
to be exogenous (Hansen=0.575).
Table 6.1: Estimation Results for Productivity using OLS and WG and the HSCL-
20 mental health measure
Variable OLS levels Within groups
Productivity t− 1 0.405 (0.027) *** -0.085 (0.039) **
Attendance t− 1 -0.023 (0.009) *** 0.029 (0.011) ***
HSCL-20 depression measure t -0.035 (0.013) *** -0.047 (0.018) ***
SF-12 physical health measure t 0.003 (0.001) *** 0.001 (0.002)
Continue current medication t− 1 0.003 (0.028) 0.037 (-0.950)
Switch medications t− 1 -0.011 (0.042) 0.049 (-0.800)
Unemployment rate by zipcode t -0.001 (0.002) 0.068 (0.039) *
Age squared t 0.000 (0.000) 0.000 (0.000)
Age female interaction t 0.000 (0.000) -0.029 (0.041)
Note: 254 individuals, 839 observations, 5 available interviews. Month dummies in-
cluded in all specifications (coefficients are not reported). *significant at 10%; **signif-
icant at 5%, ***significant at 1%.
The estimated coefficients using GMM are presented in the top panel of Table 6.2. Both
methods result in similar estimates indicating that improvements in the HSCL-20 mental
health scores do have a significant and positive effect on the worker’s productivity score.
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Table 6.2: Estimation Results for Productivity using GMM and the HSCL-20 mental health
measure
Variable First Differences Forward Orthogonal Deviations
∆ Productivity t− 1 0.090 (0.101) 0.062 (0.100)
∆ Attendance t− 1 0.009 (0.020) 0.005 (0.021)
∆ HSCL-20 depression measure -0.075 (0.026) *** -0.060 (0.023) ***
∆ SF-12 physical health measure 0.003 (0.010) 0.003 (0.011)
∆ Continue current medication 0.007 (0.145) 0.079 (0.125)
∆ Switch medications -0.061 (0.121) -0.126 (0.105)
∆ Unemployment rate by zipcode 0.128 (0.047) *** 0.140 (0.035) ***
∆ Age squared 0.000 (0.000) 0.000 (0.000)
∆ Age female interaction -0.028 (0.066) -0.029 (0.039)
Serial Correlation (m1) p-value 0.00 0.00
Serial Correlation (m2) p-value 0.072 0.051
Hansen Statistic 0.586 0.575
Instruments (Full) 47 47
Note: 221 individuals, 575 observations, 5 available interviews. Month dummies included in all
specifications (coefficients are not reported). *significant at 10%, **significant at 5%, ***sig-
nificant at 1%. The reported results are two-step estimates with heteroskedasticity consistent
errors and adjusted using the Windmeijer (2005) finite sample correction.
Using FD, a one point improvement in HSCL-20 mental health score (a decrease in HSCL-20
score) results in a 7.50% improvement in the productivity measure. Using the full sample
of individuals, with a mean HSCL-20 score equal to 1.68 at baseline, a 1 point improvement
(decrease in score) would indicate that the individual’s mental health had improved and
that the individual would be categorized as having mild depression rather than moderate
depression. The WLQ scale score ranges from 0 (limited all of the time) to 100 (limited
none of the time) and represents the amount of time that the worker was limited on the
job in the previous two weeks. Using an algorithm, Lerner et al (2001) translated WLQ
scores into an estimate of productivity loss when compared to a healthy sample.1 Using these
estimates and the full sample at baseline with a mean productivity score equal to 74.62, the
significant 7.50% change in productivity (to a productivity index score of 80.21) indicates an
improvement in productivity of approximately 4 percent (from a 22.10% relative decrease to
an 18.10% relative decrease) when compared to a healthy worker. This translates into a 6%
1See Appendix E.
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decrease in work hours to compensate for the loss in productivity due to depressive symptoms.
The unemployment rate is significant with the expected sign indicating that when there is
a one point change in the unemployment rate in an area the worker’s productivity increases
by 13.00%. The lagged productivity measure is not significant. Similarly to when using first
differencing, using FOD indicates that the mental health coefficient is negative and significant
with a similar value (coefficient=-0.06). This indicates that a one point decrease in HSCL-20
score results in a six percent change (improvement) in the work productivity measure. Again,
deviations in unemployment rates do have a significant effect on productivity. Though the
lagged productivity measure is not significant, its coefficient does fall within the desired upper
and lower bounds given by the OLS and WG estimates.
Tables 6.3 and 6.4 report the same specification as found in Tables 6.1 and 6.2 using the
SF-12 mental health scale rather than the HSCL-20 score to measure depression outcome.
Unlike the HSCL-20 scale, the SF-12 is positively scored with higher scores indicating better
mental health. Again, both sets of estimates fulfill all specification requirements. The same
variables are determined to be significant with the same expected signs. Estimates indicate
that a one point increase in the SF-12 mental health score leads to improvements in the
productivity measure of less than one percent. With a mean SF-12 score equal to 32.48 at
baseline, a 1 point improvement to 33.48 would indicate that the individual’s mental health
had improved but, using the preferred cut-off score of 42, the individual would still meet
the National Institutes for Mental Health (NIMH) criteria for major depression. Using these
estimates and the full sample at baseline with a mean productivity score equal to 74.62, the
significant change in productivity is negligible when compared to a healthy worker. Across
all estimations methods, there is strong evidence that improvements in mental health do lead
to improvements in productivity.
To compare more similar groups, I divide the sample into two groups- those with either
severe depression or moderate depression at baseline and those with mild or remissive de-
pression at baseline. This is to determine if the mental health improvements have similar
effects for both groups of workers. GMM (using the HSCL-20) results are presented in Tables
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Table 6.3: Estimation Results for Productivity using OLS and WG and the SF-12
mental health measure
Variable OLS levels Within groups
Productivity t− 1 0.408 (0.027) *** -0.067 (0.038) ***
Attendance t− 1 -0.023 (0.009) *** 0.032 (0.011) ***
SF-12 depression measure t 0.002 (0.000) *** 0.002 (0.001) *
SF-12 physical health measure t 0.004 (0.001) *** 0.001 (0.002)
Continue current medication t− 1 0.008 (0.028) * -0.036 (0.037)
Switch medications t− 1 -0.005 (0.042) -0.035 (0.049)
Unemployment rate by zipcode t -0.001 (0.002) 0.073 (0.039)
Age squared t 0.000 (0.000) 0.000 (0.000)
Age female interaction t 0.000 (0.000) -0.034 (0.042)
Note: 254 individuals, 839 observations, 5 available interviews. Month dummies in-
cluded in all specifications (coefficients are not reported). *significant at 10%, **sig-
nificant at 5%, ***significant at 1%.
Table 6.4: Estimation Results for Productivity using GMM and the SF-12 mental health
measure
Variable First Differences Forward Orthogonal Deviations
∆ Productivity t− 1 0.026 (0.096) 0.060 (0.100)
∆ Attendance t− 1 0.011 (0.020) 0.007 (0.019)
∆ SF-12 depression measure 0.003 (0.001) ** 0.002 (0.001) **
∆ SF-12 physical health measure 0.003 (0.009) *** 0.005 (0.010)
∆ Continue current medication -0.083 (0.159) -0.145 (0.119)
∆ Switch medications -0.108 (0.123) -0.146 (0.101)
∆ Unemployment rate by zipcode 0.133 (0.047) *** 0.158 (0.036) ***
∆ Age squared 0.000 (0.000) 0.000 (0.000)
∆ Age female interaction -0.039 (0.064) -0.036 (0.037)
Serial Correlation (m1) p-value 0.001 0.001
Serial Correlation (m2) p-value 0.079 0.069
Hansen 0.801 0.819
Instruments (Full) 47 47
Note: 221 individuals, 575 observations, 5 available interviews. Month dummies included in all
specifications (coefficients are not reported). *significant at 10%, **significant at 5%, ***sig-
nificant at 1%. The reported results are two-step estimates with heteroskedasticity consistent
errors and adjusted using the Windmeijer (2005) finite sample correction.
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6.5-6.6.2 For the more depressed sample, improvements in mental health have a significant
and positive effect on productivity (t=2.82). When comparing results from Table 6.2 and
Table 6.5, estimated coefficients and standard deviations for the relatively more depressed
sample are similar to those for the whole sample. This is expected since 61.20% of the full
sample are characterized as either having moderate or severe depression at baseline versus
only 38.73% of the sample determined to be as either having mild depression or being in
remission initially. For those who were less depressed at baseline the change in mental health
is no longer a significant determinant of productivity outcomes. The standard deviation for
the least depressed group is much larger than for the full sample or the more depressed sub-
sample. However, physical health becomes a significant determinant of productivity at the
10% level when using FOD. Unexpectedly, the coefficient is negative indicating that an im-
provement in physical health leads to a decrease in productivity. This could be due to the
self report of health indicators.
The results indicate that accounting for the endogeneity of different variables, dynamic
panel bias and the selection bias in the model gives different results of effects of depression
changes on productivity. OLS coefficients underestimate effects of depression on productivity.
When accounting for the effect of unobserved heterogeneity, the WG coefficients increase for
the HSCL-20 measure and stay the same using the SF-12 measure for depression.
6.1.2 Absenteeism
The categorical attendance scale is treated as a linear variable in all specifications. At-
tendance estimates are found in Tables 6.7-6.12. Regardless of the differencing method or the
mental health measure, improvements in mental health do not have a significant effect on a
worker’s attendance at work except for with the most depressed at baseline sub-sample.
As with the presenteeism equations, specification tests are discussed before the estimated
coefficients. Table 6.7 includes both OLS in levels and WG estimates for the absenteeism
specification using the HSCL-20 score as the measure for mental health. Mental health is
not a significant and determinant of a worker’s ability to meet the number of required work
2I only present HSCL-20 GMM estimates as SF-12 results are similar.
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Table 6.5: Estimation Results for Productivity using GMM and the HSCL-20 mental health
measure for the most depressed sample at baseline
Variable First Differences Forward Orthogonal Deviations
∆ Productivity t− 1 0.046 (0.118) *** 0.073 (0.117)
∆ Attendance t− 1 -0.004 (0.026) *** -0.010 (0.024)
∆ HSCL-20 depression measure -0.074 (0.028) *** -0.072 (0.025) ***
∆ SF-12 physical health measure 0.009 (0.009) 0.010 (0.009)
∆ Continue current medication 0.116 (0.190) 0.079 (0.188)
∆ Switch medications -0.040 (0.176) -0.065 (0.159)
∆ Unemployment rate by zipcode 0.047 (0.031) 0.095 (0.033) ***
∆ Age squared 0.001 (0.000) 0.001 (0.000)
∆ Age female interaction -0.015 (0.091) -0.053 (0.061)
Serial Correlation (m1) p-value 0.007 0.004
Serial Correlation (m2) p-value 0.410 0.552
Hansen Statistic 0.563 0.621
Instruments (Full) 47 47
Note: 130 individuals, 335 observations, 5 available interviews. Month dummies included in all
specifications (coefficients are not reported). *significant at 10%, **significant at 5%, ***sig-
nificant at 1%. The reported results are two-step estimates with heteroskedasticity consistent
errors and adjusted using the Windmeijer (2005) finite sample correction.
Table 6.6: Estimation Results for Productivity using GMM and the HSCL-20 mental
health measure for the least depressed sample at baseline
Variable First Differences Forward Orthogonal Deviations
∆ Productivity t− 1 0.105 (0.113) 0.142 (0.117)
∆ Attendance t− 1 -0.007 (0.028) -0.002 (0.024)
∆ HSCL-20 depression measure -0.061 (0.055) -0.059 (0.051)
∆ SF-12 physical health measure -0.009 (0.006) -0.010 (0.006) *
∆ Continue current medication 0.055 (0.132) 0.052 (0.113)
∆ Switch medications 0.086 (0.128) 0.076 (0.100)
∆ Unemployment rate by zipcode 0.317 (0.380) 0.123 (0.290)
∆ Age squared 0.000 (0.000) 0.000 (0.000)
∆ Age female interaction 0.000 (0.000) -0.071 (0.055)
Serial Correlation (m1) p-value 0.022 0.012
Serial Correlation (m2) p-value 0.555 0.535
Hansen Statistic 0.430 0.354
Instruments (Full) 47 47
Note: 91 individuals, 240 observations, 5 available interviews. Month dummies included in
all specifications (coefficients are not reported). *significant at 10%, **significant at 5%,
***significant at 1%. The reported results are two-step estimates with heteroskedasticity
consistent errors and adjusted using the Windmeijer (2005) finite sample correction.
47
hours using both methods. In Table 6.8, the Hansen test p-value is 0.412, indicating that the
null can not be rejected at the 5% significance level. The p-value testing for second order
serial correlation is above the 5% significance level critical value (m2=0.886), thus implying
that there is no second-order serial correlation present and that the estimates are consistent.
As expected, first order correlation is present due to first differencing (m1=0.00). There
are 47 total instruments, which is less than the number of observations. Additionally, the
estimate of the parameter on lagged attendance measure does fall within the desired range
determined from the OLS and WG estimates. The estimated coefficients in Tables 6.8-6.10
indicate that improvements in mental health do not significantly affect the worker’s work
attendance regardless of the transformation method or depression score that is used.
Results indicate that lagged absenteeism is significant using either FD or FOD and the
HSCL-20 or SF-12 scores. Physical health changes significantly affect attendance when using
FOD to remove the unobserved heterogeneity and the HSCL-20 score (t=1.95).
Results differ when divided into the two groups- the more depressed individuals at baseline
and those less depressed at baseline. The results for the most depressed individuals are found
in Table 6.11 and indicate that mental health changes do affect the worker’s attendance at
the 90% confidence level. Changes in depressive levels are not significant determinants of
attendance for the less depressed group as seen in Table 6.12.
Table 6.7: Estimation Results for Attendance using OLS and WG and the HSCL-
20 mental health measure
Variable OLS levels Within groups
Attendance t− 1 0.201 (0.032) *** -0.193 (0.003) ***
Productivity t− 1 -0.006 (0.002) *** 0.007 (0.003) ***
HSCL-20 depression measure t -0.044 (0.047) 0.006 (0.070)
SF-12 physical health measure t 0.023 (0.003) *** 0.025 (0.006) ***
Continue current medication t− 1 0.065 (0.098) 0.067 (0.131)
Switch medications t− 1 0.049 (0.147) 0.090 (0.173)
Unemployment rate by zipcode t -0.004 (0.009) -0.047 (0.137)
Age squared t 0.000 (0.000) .000 (0.001)
Age female interaction t -0.001 (0.001) -0.011 (0.146)
Note: 254 individuals, 839 observations, 5 available interviews. Month dummies in-
cluded in all specifications (coefficients are not reported). *significant at 10%, **sig-
nificant at 5%, ***significant at 1%.
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Table 6.8: Estimation Results for Attendance using GMM and the HSCL-20 mental health
measure
Variable First Differences Forward Orthogonal Deviations
∆ Attendance t− 1 0.167 (0.083) ** 0.186 (0.076) ***
∆ Productivity t− 1 -0.010 (0.005) -0.002 (0.005)
∆ HSCL-20 depression measure -0.076 (0.139) -0.007 (0.129)
∆ SF-12 physical health measure 0.065 (0.040) 0.082 (0.042) *
∆ Continue current medication 0.185 (0.603) 0.017 (0.587)
∆ Switch medications 0.066 (0.547) -0.012 (0.525)
∆ Unemployment rate by zipcode 0.080 (0.139) 0.063 (0.115)
∆ Age squared 0.002 (0.002) 0.001 (0.002)
∆ Age female interaction -0.278 (0.222) -0.132 (0.181)
Serial Correlation (m1) p-value 0.000 0.000
Serial Correlation (m2) p-value 0.886 0.989
Hansen Statistic 0.412 0.426
Instruments (Full) 47 47
Note: 221 individuals, 575 observations, 5 available interviews. Month dummies included in all
specifications (coefficients are not reported). *significant at 10%, **significant at 5%, ***sig-
nificant at 1%. The reported results are two-step estimates with heteroskedasticity consistent
errors and adjusted using the Windmeijer (2005) finite sample correction.
49
Table 6.9: Estimation Results for Attendance using OLS, WG and the SF-12
mental health measure
Variable OLS levels Within groups
Attendance t− 1 0.203 (0.032) *** -0.188 (0.040) ***
Productivity t− 1 -0.006 (0.002) *** 0.009 (0.003) ***
HSCL-20 depression measure t 0.002 (0.003) -0.004 (0.004)
SF-12 physical health measure t 0.024 (0.003) *** -0.025 (0.006) ***
Continue current medication t− 1 0.069 (0.098) 0.056 (0.131)
Switch medications t− 1 -0.053 (0.147) 0.080 (0.173)
Unemployment rate by zipcode t -0.005 (0.009) -0.050 (0.137)
Age squared t 0.000 (0.000) 0.000 (0.001)
Age female interaction variable t -0.001 (0.001) -0.006 (0.146)
Note: 254 individuals, 839 observations, 5 available interviews. Month dummies in-
cluded in all specifications (coefficients are not reported). *significant at 10%, **sig-
nificant at 5%, ***significant at 1%.
Table 6.10: Estimation Results for Attendance using GMM and the SF-12 mental health
measure
Variable First Differences Forward Orthogonal Deviations
∆ Attendance t− 1 0.145 (0.075) * 0.142 (0.071) **
∆ Productivity t− 1 -0.004 (0.005) -0.005 (0.005)
∆ HSCL-20 depression measure -0.005 (0.006) -0.004 (0.006)
∆ SF-12 physical health measure 0.027 (0.032) 0.040 (0.032)
∆ Continue current medication -0.373 (0.542) -0.413 (0.479)
∆ Switch medications -0.357 (0.581) -0.371 (0.523)
∆ Unemployment rate by zipcode -0.036 (0.115) -0.027 (0.130) *
∆ Age squared 0.002 (0.002) 0.001 (0.002)
∆ Age female interaction -0.190 (0.221) -0.089 (0.173)
Serial Correlation (m1) p-value 0.000 0.000
Serial Correlation (m2) p-value 0.504 0.562
Hansen Statistic 0.327 0.310
Instruments (Full) 47 47
Note: 221 individuals, 575 observations, 5 available interviews. Month dummies included
in all specifications (coefficients are not reported). *significant at 10%, **significant at 5%,
***significant at 1%. The reported results are two-step estimates with heteroskedasticity
consistent errors and adjusted using the Windmeijer (2005) finite sample correction.
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Table 6.11: Estimation Results for Attendance using GMM and the SF-12 mental health
measure for the most depressed sample at baseline
Variable First Differences Forward Orthogonal Deviations
∆ Attendance t 0.156 (0.100) 0.115 (0.094)
∆ Productivity t -0.004 (0.009) -0.007 (0.007)
∆ SF-12 depression measure -0.017 (0.010) * -0.018 (0.010) *
∆ SF-12 physical health measure -0.035 (0.045) -0.041 (0.048)
∆ Continue current medication -0.435 (0.956) -0.264 (1.055)
∆ Switch medications -0.107 (1.006) 0.053 (1.080)
∆ Unemployment rate by zipcode 0.029 (0.108) -0.219 (0.251)
∆ Age squared 0.001 (0.003) -0.001 (0.003)
∆ Age female interaction 0.026 (0.308) 0.081 (0.295)
Serial Correlation (m1) p-value 0.002 0.001
Serial Correlation (m2) p-value 0.162 0.236
Hansen Statistic 0.142 0.251
Instruments (Full) 47 47
Note: 130 individuals, 335 observations, 5 available interviews. Month dummies included
in all specifications (coefficients are not reported). *significant at 10%, **significant at 5%,
***significant at 1%. The reported results are two-step estimates with heteroskedasticity
consistent errors and adjusted using the Windmeijer (2005) finite sample correction.
Table 6.12: GMM estimates for Attendance and Mental Health using the SF-12 mental
health measure for the least depressed sample at baseline
Variable First Differences Forward Orthogonal Deviations
∆ Attendance t− 1 -0.093 0.159 -0.059 0.167
∆ Productivity t− 1 -0.128 0.007 *** -0.013 0.008
∆ SF-12 depression measure 0.011 0.009 0.008 0.008
∆ SF-12 physical health measure 0.047 0.028 * 0.052 0.029 *
∆ Continue current medication - 0.249 0.393 -0.316 0.375
∆ Switch medications -0.305 0.520 -0.384 -0.496
∆ Unemployment rate by zipcode -0.957 0.811 0.384 0.534
∆ Age squared -0.000 0.002 .000 .002
∆ Age female interaction 0.342 0.000 -0.104 0.272
Serial Correlation (m1) p-value 0.037 0.030
Serial Correlation (m2) p-value 0.476 0.463
Hansen Statistic 0.334 0.536
Instruments (Full) 47 47
Note: 91 individuals, 240 observations, 5 available interviews. Month dummies included in all
specifications (coefficients are not reported). *significant at 10%, **significant at 5%, ***sig-
nificant at 1%. The reported results are two-step estimates with heteroskedasticity consistent
errors and adjusted using the Windmeijer (2005) finite sample correction.
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Chapter 7
Conclusion
Using different estimation techniques and measures of mental health status, this research
provides a better understanding of the relationships between depression, treatment decisions
and employment outcomes for a sample of initially depressed individuals. After using several
methods to account for the endogeneity of different variables, the results consistently indi-
cate that depression severity has a significant effect on a worker’s productivity if employed.
However, it is seen that depression does not significantly affect the worker’s attendance. One
possible explanation is that the worker attends work but performs at a low level of productiv-
ity in order to maintain employment for income or other benefits including health insurance.
Additionally, results are consistent with the literature that the most depressed sub sample
experiences the largest change in performance.
The results are consistent with the conclusion that it is important for a firm to consider
productivity and not just attendance at work. If the workers are still coming to work, but
are not efficient, it can be a major yet often overlooked cost to the employer.
It is always important to address possible problems with the results. I do not model
attrition in the ARTIST trial or in the individual’s decisions to continue, switch or stop
treatment. It is also important to note that these individuals sought depressive treatment
and participated in the treatment trial. This could lead to additional selection issues. A
benefit is that people act as their own control and there will be less baised based on recall of
health choices, outcomes and employment outcomes.
Appendix A
Sample Characteristics by Participation
Pattern
Sample attrition is a potential source of selection bias in this study. It arises as certain
participants drop out of the study before completing each of the five interviews. Here, the
researcher does not know why the individual drops out of the sample. Possible explanations
that are systematically related to the response variable include no change in mental health,
or a recovery from depression. Death is also a possibility.
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Appendix B
Questions from the 36-item Short-form
Health Survey (SF-36)
1. During the past 4 weeks have you had any of the following problems with your work
or other regular daily activities as a result of any emotional problems (such as feeling
depressed or anxious)?
(a) Cut down the amount of time you spent on work or other activities (Role Emo-
tional; Yes, No)
(b) Accomplished less than you would like (Role Emotional; Yes, No)
(c) Didn’t do work or other activities as carefully as usual (Role Emotional; Yes, No)
2. During the past 4 weeks, to what extent has your physical or emotional problems in-
terfered with your normal social activities with family, friends, neighbors or groups?
(Social Functioning; Not at all, Slightly, Moderately, Quite a bit, Extremely)
3. These questions are about how you feel and how things have been with you during the
past 4 weeks. For each question, please give the one answer that comes closest to the
way you have been feeling. How much of the time during the past 4 weeks
(a) Did you feel full of pep? (Vitality; All of the time, Most of the time, A good bit
of the time, Some of the time, A little of the time, None of the time)
(b) Have you been a very nervous person? (Mental Health; All of the time, Most of
the time, A good bit of the time, Some of the time, A little of the time, None of
the time)
56
(c) Have you felt so down in the dumps that nothing could cheer you up? (Mental
Health; All of the time, Most of the time, A good bit of the time, Some of the
time, A little of the time, None of the time)
(d) Have you felt calm and peaceful? (Mental Health; All of the time, Most of the
time, A good bit of the time, Some of the time, A little of the time, None of the
time)
(e) Did you have a lot of energy? (Vitality; All of the time, Most of the time, A good
bit of the time, Some of the time, A little of the time, None of the time)
(f) Have you felt downhearted and blue? (Mental Health; All of the time, Most of the
time, A good bit of the time, Some of the time, A little of the time, None of the
time)
(g) Did you feel worn out? (Vitality; All of the time, Most of the time, A good bit of
the time, Some of the time, A little of the time, None of the time)
(h) Have you been a happy person? (Mental Health; All of the time, Most of the time,
A good bit of the time, Some of the time, A little of the time, None of the time)
(i) Did you feel tired? (Vitality; All of the time, Most of the time, A good bit of the
time, Some of the time, A little of the time, None of the time)
4. During the past 4 weeks, how much of the time has your physical health or emotional
problems interfered with your social activities (like visiting with friends, relatives etc.)?
(Social Functioning; All of the time, Most of the time, A good bit of the time, Some of
the time, A little of the time, None of the time)
Each item is used in scoring only one scale. The scores from each of the four scales are
then combined to attain the mental component summary score.
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Appendix C
Productivity Questions from the Work
Limitations Questionnaire
A productivity scale is created from five questionnaire items. Conditional on working, a
negatively scored scale is used with a higher score indicating more limitation. The response
choices are: All of the time, Most of the time, Some of the time, A slight bit of the time,and
None of the time.1 The questionnaire items include:
1. How much of the time during the past two weeks did you finish work on time?
2. How much of the time during the past two weeks did you do your work without making
mistakes?
3. How much of the time during the past two weeks did you feel you’ve done what you are
capable of doing?
4. How much of the time during the past two weeks did your physical health or emotional
problems make it difficult for you to handle the workload?
5. How much of the time during the past two weeks did your physical health or emotional
problems make it difficult for you to work fast enough?
1See WLQ for scoring algorithm.
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Appendix D
Zipcode Tabulation Areas
Zip code information is included in the ARTIST trial data set at each interview. Zip
code information is included in this study; however, Zip Code Tabulation Areas are used
for extracting information on a geographic area from the given zip code. The United States
Census Bureau describes them,
ZIP Code Tabulation Areas (ZCTAs) are a new statistical entity developed
by the U.S. Census Bureau for tabulating summary statistics from Census 2000.
This new entity was developed to overcome the difficulties in precisely defining the
land area covered by each ZIP Code. Defining the extent of an area is necessary
in order to accurately tabulate census data for that area. ZCTAs are generalized
area representations of U.S. Postal Service (USPS) ZIP Code service areas. Simply
put, each one is built by aggregating the Census 2000 blocks, whose addresses use
a given ZIP Code, into a ZCTA which gets that ZIP Code assigned as its ZCTA
code. They represent the majority USPS five-digit ZIP Code found in a given
area. For those areas where it is difficult to determine the prevailing five-digit
ZIP Code, the higher-level three-digit ZIP Code is used for the ZCTA code. It
is important to note the following: In most instances the ZCTA code equals the
ZIP Code for an area In creating ZCTAs, the Census Bureau took the ZIP Code
used by the majority of addresses in a area for the ZCTA code, some addresses
will end up with a ZCTA code different from their ZIP Code. Some ZIP Codes
represent very few addresses (sometimes only one) and therefore will not appear
in the ZCTA universe. The term ZCTA was created to differentiate between this
entity and true USPS ZIP Codes. Information on the Census Bureau’s position
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regarding ZIP Code data. ZCTA is a trademark of the U.S. Census Bureau; ZIP
Code is a registered trademark of the U.S. Postal Service.
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Appendix E
The Work Limitations Questionnaire:
Estimated Productivity Impact of
Health-Related Work Limitations Based on
WLQ Index Score
Table E.1: The Work Limitations Questionnaire: Estimated Productivity Impact of Health-
Related Work Limitations Based on WLQ Index Score
WLQ % decrease in % increase in work
Index Score productivity hours to compensate
(compared to healthy) for productivity loss
100 - -
95 4.9 5.1
90 9.5 10.5
85 14.1 16.2
80 18.1 22.1
75 22.1 28.4
70 25.9 34.9
65 29.5 41.9
60 32.9 49.2
55 36.2 56.8
50 39.4 64.9
I report WLQ Index Scores on a positive scale with a higher score indicating better labor outcomes.
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Appendix F
The GMM Estimator
The GMM estimator based on these moment conditions minimises the limiting variance
of the sample moments,
V =
(
1
N
N∑
i=1
∆ν ′iZi
)(
1
N
N∑
i=1
Z ′i∆νi
)
. (F.1)
Let
L =

L1
...
LN
 , X =

X1
...
XN
 , and νi =

ν1
...
νN
 .
The optimal GMM estimator is then
Θˆ = (X ′Z ′Vˆ −1Z ′X)−1X ′ZVˆ −1Z ′L (F.2)
where Vˆ is a consistent estimate of V . Generally, the optimal Vˆ is
Vˆ =
1
N
N∑
i=1
Z ′iνˆiνˆi
′Zi (F.3)
where νˆi is an estimate of the vector of residuals νit. This vector of residuals is obtained
from an initial consistent estimator. For this initial consistent estimator, Arellano and Bond
(1991) use
Vˆc =
1
N
N∑
i=1
Z ′iHZi, (F.4)
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where for T = 5,
H =

2 −1 0
−1 2 −1
0 −1 2
 .
With T fixed at 5 and N → ∞, the resulting Θˆ ∼ N(Θ,∑) is consistent. Generally, the
GMM estimator based on these moment conditions minimises
JN =
(
1
N
N∑
i=1
∆µ′iZi
)
WN
(
1
N
N∑
i=1
Z ′i∆µi
)
(F.5)
using the weight matrix
WN =
[
1
N
N∑
i=1
(
Z ′i∆̂µi∆̂µi
′
Zi
)]−1
. (F.6)
Standard errors for the transformed estimates are obtained by taking the square root of the
diagonal of sigma. With heteroskedastic disturbances, the two-step estimator is more efficient.
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Appendix G
Additional Information on Variables
Table G.1: Constant Explanatory Variables- Definitions
Variable Definition
Female Dummy variable=1 if female, =0 if male
Race
White =1 if white, =0 otherwise
Black =1 if black, =0 otherwise
Asian =1 if asian, =0 otherwise
Other =1 if other race, =0 otherwise
Evertreated =1 if evertreated for depression prior to study, =0 otherwise
Randomized Drug SSRI randomized
Paxil =1 if Paxil randomized, =0 otherwise
Prozac =1 if Prozac randomized, =0 otherwise
Zoloft =1 if Zoloft randomized, =0 otherwise
Same Drug =1 if randomized drug= prescribed drug, =0 otherwise
Table G.2: Summary of First-Differenced Characteristics of Sample
∆ Characteristic Mean SD
∆ Mental Health HSCL-20 score -0.230 0 .559
∆ Mental Health SF-12 score 4.195 10.352
∆ Physical Health SF-12 score 0.443 7.053
∆ Productivity 3.560 16.347
∆ Attendance 0.132 0.379
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